Alcon AG vs CSX Corporation — how do they compare? Alcon AG trades at $72.48 (market cap $36.44B), while CSX Corporation trades at $50.1 (market cap $92.55B). The key difference: CSX Corporation is far larger — about 2.5× Alcon AG's market cap, and CSX Corporation pays the higher dividend (1.12%). Which is the better fit depends on your goals.
| ALC | CSX | |
|---|---|---|
Market Cap | $36.44B | $92.55B |
Sector | Health | Industrials |
52-Week High | $90.12 | $53.21 |
52-Week Low | $62.02 | $32.05 |
Enterprise Value | $40.28B | $110.52B |
Dividend Yield | 0.48% | 1.12% |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →